arrow
O

Olga Pozdnyakova

pathology
H指数:26
被引数:3,468

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicing

突变SRSF2相关的红细胞生成障碍是由FYN剪接错误导致的mTORC1信号增强所定义。

Leukemia
IF13.4
2026-02-260
PRE
Next-generation morphology, a novel multilayer morphometric digital analysis, reveals both the basic topology and new trends of myelodysplasia of peripheral blood specimens

下一代形态学,一种新颖的多层形态测量数字分析方法,揭示了外周血样本中骨髓发育不良的基本拓扑结构和新趋势。

2025-08-290
OAAI
Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation

赖氨酸特异性去甲基化酶1调控造血干细胞扩增和髓系细胞分化

2025-08-150
OA
A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial
2024-01-251
OAAI
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow
2024-01-012
PRE
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial
2023-05-119
OAAI
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements
2023-02-014
OAAI
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group (Nov, 10.1038/s41379-021-00961-0, 2021)
2022-05-011
OA
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group
2022-04-0112
OAAI
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial
2022-03-3113
OAAI